NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: After NF-κB signaling is activated, upregulation of the apoptosis gene inhibitor allows CML cells to avoid the apoptosis effects of chemotherapeutic drugs and induce drug resistance.